NGM·Healthcare·$455M·#181 / 520 in Healthcare
BBNX Beta Bionics, Inc.
55SPECULATIVE
CATEGORY BREAKDOWN
GROWTH82
QUALITY50
STABILITY44
VALUATION79
GOVERNANCE33
METRIC BREAKDOWN
Revenue Growth (YoY)
Year-over-year revenue growth rate
+53.9%
82
> 50% strong
Gross Margin
Revenue retained after direct costs
55.4%
78
> 50% strong
Cash Runway
Months of cash at current burn rate
7 months
17
> 24 months ideal
Debt / Equity
Total debt relative to shareholder equity
2.5%
98
< 25% strong
Price / Sales
Market cap relative to trailing revenue
4.1x
79
< 3x strong
Rule of 40
Growth rate plus operating margin
-18
7
> 40 excellent
Insider Ownership
Percentage of shares held by insiders
1.0%
8
> 20% strong
Share Dilution (12M)
Share count increase over last 12 months
+2.5%
85
< 5% ideal
SCORE HISTORY
RELATED STOCKS
COMPARE BBNX WITH…
OR QUICK-COMPARE SECTOR PEERS
SCORE ALERT
Get notified when BBNX's score changes by 5+ points.
DATA INFO
Last updated: May 4, 2026
Sources: SEC EDGAR, Financial Modeling Prep, Yahoo Finance. Not financial advice.